Indian Vaccine

Indian Vaccine News

COVID-19: Indian vaccines sold in Europe for first time, says Adar Poonawalla; lauds Centre's work during pandemic
India

COVID-19: Indian vaccines sold in Europe for first time, says Adar Poonawalla; lauds Centre's work during pandemic

On 9 April, Poonawalla said in a tweet that SII had decided to revise the price of Covishield vaccine for private hospitals from Rs 600 to Rs 225 per dose

WHO suspends Bharat Biotech's Covaxin supply for UN procurement agencies citing 'deficiencies'
India

WHO suspends Bharat Biotech's Covaxin supply for UN procurement agencies citing 'deficiencies'

The international health body, however, maintained that data available on India’s first indigenous COVID-19 vaccine indicated that it was effective and there were no safety concerns

India's first homegrown mRNA vaccine likely to begin trials on humans in Feb, say sources
India

India's first homegrown mRNA vaccine likely to begin trials on humans in Feb, say sources

Gennova Biopharmaceuticals has also developed the mRNA vaccine for the Omicron variant that will be tested on humans for efficacy and immunogenicity soon, the official sources said

Biological E seeks DCGI approval to conduct Phase 3 trials for Corbevax as booster dose for Covishield, Covaxin
India

Biological E seeks DCGI approval to conduct Phase 3 trials for Corbevax as booster dose for Covishield, Covaxin

Currently, phase 2/3 trials of the RBD protein sub-unit vaccine is underway and the results are likely to be declared this month.

I got Covishield from India, says President of the 76th UN General Assembly Abdulla Shahid
World

I got Covishield from India, says President of the 76th UN General Assembly Abdulla Shahid

India has exported over 66 million doses to nearly 100 countries, including the Maldives, Shahid's home country

Manufacturing and testing a batch of COVAXIN takes 120 days, says Bharat Biotech
India

Manufacturing and testing a batch of COVAXIN takes 120 days, says Bharat Biotech

Manufacturing, testing, release and distribution are a complex process with hundreds of steps, requiring a diverse pool of human resources.

Distributing COVID-19 vaccines without rich countries cornering doses will be a challenge: WHO's Soumya Swaminathan
science

Distributing COVID-19 vaccines without rich countries cornering doses will be a challenge: WHO's Soumya Swaminathan

India is a hub for vaccines since many companies are working on vaccine development, either on their own or in collaboration.